Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Wolff

16 indexed publications match this author name.

ORCID: 0000-0001-6896-9633
OpenAlex: https://openalex.org/A5137114818

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 8 Treatment-Resistant Depression 5 Safety 5 Clinical Trial 4 Chronic Pain 3 Mechanism of Action 3 Adverse Events 2 Pharmacology 2 Randomized Controlled Trial 2 Receptor Pharmacology 2 Consciousness 2 Toxicity 2

Journals

Psychotherapy and Psychosomatics 1 JAMA Psychiatry 1 PsyArXiv 1 Journal of affective disorders 1 Neuroscience Applied 1 Journal of eating disorders 1 Der Nervenarzt 1 Nature communications 1

Publication history

Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-27 Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-05-01 Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”PsyArXiv · 2026-03-30 Pharmacodynamic biomarker - or psychotherapeutic process? Comment on "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression".Journal of affective disorders · 2026-02-01 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trialNeuroscience Applied · 2026-01-01 Questioning the recovery of dissociated traumatic memories under psilocybin: comment on "Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa".Journal of eating disorders · 2025-12-04 [Acceptance of psilocybin-assisted therapy in German-speaking countries].Der Nervenarzt · 2025-11-01 Serotonin and psilocybin activate 5-HT receptors to suppress cortical signaling through the claustrum.Nature communications · 2025-08-19 A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01 Akzeptanz psilocybin-assistierter Therapie in den deutschsprachigen Ländernedoc Publication server (Humboldt University of Berlin) · 2025-02-12 [Attitudes of Mental Health Experts Towards Psilocybin].Fortschritte der Neurologie-Psychiatrie · 2023-03-01 The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility.Journal of psychopharmacology (Oxford, England) · 2022-03-01 Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.Neuroscience applied · 2022-01-01 P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current statusEuropean Neuropsychopharmacology · 2021-12-01 Modulatory effects of ayahuasca on personality structure in a traditional framework.Psychopharmacology · 2020-10-01 Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance.Frontiers in psychiatry · 2020-01-01

Author directory